Amneal Pharmaceuticals, Inc. Financial Ratios — AMRX Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	24.99	-5.96	-9.03	2.37	0.27	-3.36	-2.31	-3.35	2.01
Return on Capital (%)	- -	31.6	- -	- -	- -	3.34	- -	- -	- -	11.47
Return on Invested Capital (%)	- -	70.3	- -	- -	- -	4.65	- -	- -	- -	19.62
Gross Margin (%)	58.68	50.9	43.08	21.7	31.54	36.73	35.47	34.28	36.52	36.88
EBITDA Margin (%)	30.15	26.23	24.99	4.2	17.39	20.41	19.4	19.56	20.92	20.59
Operating Margin (%)	26.9	21.79	16.72	-8.54	5.57	9.26	8.54	9.97	12.47	13.18
Incremental Operating Margin (%)	- -	-316.01	8.41	- -	68.27	81.89	-4.2	27.48	27.38	22.04
Pretax Margin (%)	21.1	16.57	-12.19	-13.54	-1.8	1.5	-11.22	-1.68	-1.97	4.61
Profit Margin (%)	20.37	16.22	-10.21	-22.25	4.57	0.51	-5.88	-3.51	-4.18	2.39
Net Income to Common Margin (%)	20.37	16.22	-10.21	-22.25	4.57	0.51	-5.88	-3.51	-4.18	2.39
Effective Tax Rate (%)	2.51	1.17	- -	- -	- -	35.69	- -	- -	- -	8.1
Dvd Payout Ratio (%)	94.87	219.45	-78.58	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	1,485	2,691	2,770	2,945	2,876	2,845	2,751	2,593	2,689
ST Debt	- -	89	22	37	57	46	105	228	340	22
LT Debt	- -	1,395	2,670	2,733	2,887	2,830	2,740	2,523	2,253	2,667
Total Debt/EBITDA	- -	5.48	6.48	40.53	8.5	6.73	6.63	5.88	4.44	4.33
Net Debt/EBITDA	- -	5.05	5.87	36.28	7.15	5.85	6.28	5.44	4.06	3.68
Total Debt/EBIT	- -	6.59	9.68	-19.94	26.51	14.83	15.06	11.52	7.44	6.76
Net Debt/EBIT	- -	6.08	8.77	-17.85	22.29	12.9	14.27	10.68	6.82	5.75
EBITDA to Interest Expense	5.55	3.82	2.89	0.41	2.37	3.13	2.71	2.22	2.26	2.58
EBITDA-CapEx/Interest Expense	3.3	2.21	2.22	-0.17	1.92	2.75	2.14	1.89	1.97	2.1
EBIT to Interest Expense	4.96	3.17	1.94	-0.83	0.76	1.42	1.19	1.13	1.35	1.65
Interest Expense	55	71	144	168	146	136	158	211	259	241
Common Equity/Total Assets	- -	- -	-0.41	-10.23	-7.08	-6.93	-10.61	-14.03	-17.25	-14.46
Long-Term Debt/Equity (%)	- -	- -	297.83	788.08	837.11	771.18	1,489.57	12,607.56	- -	- -
Long-Term Debt/Capital (%)	- -	93.33	87.1	108.89	106.83	108.45	117.74	111.45	113.27	123.69
Long-Term Debt/Total Assets (%)	- -	103.98	61.33	74.55	72.08	71.83	72.13	72.65	64.34	72.52
Total Debt/Equity (%)	- -	-395.32	300.26	798.74	853.77	783.72	1,546.45	13,745.06	-2,367.9	-3,769.92
Total Debt/Capital (%)	- -	99.32	87.81	110.36	108.96	110.21	122.24	121.51	130.38	124.69
Total Debt/Total Assets (%)	- -	110.65	61.83	75.56	73.51	73	74.88	79.21	74.06	73.11
Net Debt to Equity	- -	-364.84	272.06	714.94	717.69	681.5	1,465.21	12,738.16	-2,169.12	-3,210.26
Net Debt/Capital (%)	- -	96.45	85.52	105.12	104.84	105.89	117.12	117.35	126.46	122.15
EBITDA	307	271	416	68	346	427	429	468	585	621
EBITDA-CapEx	182	157	318	-29	280	375	339	399	510	507
Operating Income (Loss)	274	225	278	-139	111	194	189	239	348	398

Liquidity (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	0.25	0.39	0.27	0.5	0.37	0.03	0.11	0.1	0.32
Current Ratio	- -	2.6	2.32	2.2	2.29	2.24	1.88	1.63	1.41	2.17
Quick Ratio	- -	1.54	1.41	1.43	1.5	1.39	1.09	0.87	0.81	1.39
CFO/Avg Current Liab	- -	1.58	0.59	- -	0.62	0.36	0.09	0.43	0.3	0.34
Common Equity/Total Assets	- -	- -	-0.41	-10.23	-7.08	-6.93	-10.61	-14.03	-17.25	-14.46
Long-Term Debt/Equity (%)	- -	- -	297.83	788.08	837.11	771.18	1,489.57	12,607.56	- -	- -
Long-Term Debt/Capital (%)	- -	93.33	87.1	108.89	106.83	108.45	117.74	111.45	113.27	123.69
Long-Term Debt/Total Assets (%)	- -	103.98	61.33	74.55	72.08	71.83	72.13	72.65	64.34	72.52
Total Debt/Equity (%)	- -	-395.32	300.26	798.74	853.77	783.72	1,546.45	13,745.06	-2,367.9	-3,769.92
Total Debt/Capital (%)	- -	99.32	87.81	110.36	108.96	110.21	122.24	121.51	130.38	124.69
Total Debt/Total Assets (%)	- -	110.65	61.83	75.56	73.51	73	74.88	79.21	74.06	73.11
CFO/Total Liabilities	- -	13.64	7.24	0.05	10.35	6.77	1.8	10.01	8.17	9.07
CFO/CapEx	0.92	2.05	2.58	0.02	5.73	4.59	0.72	4.99	3.94	2.97
Altman's Z-Score	- -	2.51	1.81	0.88	1.49	1.66	1.5	1.77	2.08	2.54

Working Capital (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	5.88	3.99	3	3.21	3.22	3.15	3.53	4.02	3.61
Days Sales Outstanding	- -	62.04	91.4	121.85	113.88	113.45	115.85	103.35	90.76	101.01
Inventory Turnover	- -	3.57	2.55	3.04	3.13	2.7	2.8	2.83	2.97	3.13
Days Inventory Outstanding	- -	102.15	142.91	120.14	116.62	135.02	130.41	129.02	122.85	116.73
Accounts Payable Turnover	- -	22.61	12.11	10.99	11.51	9.31	9.89	10.49	8.97	7.4
Accounts Payable Turnover Days	- -	16.14	30.13	33.21	31.72	39.19	36.91	34.79	40.68	49.33
Cash Conversion Cycle	- -	148.04	204.18	208.78	198.78	209.27	209.35	197.58	172.93	168.41
Inventory to Cash Days	- -	-40.11	-51.51	1.71	-2.75	-21.57	-14.56	-25.67	-32.09	-15.72
Inventories	- -	284	457	381	491	489	531	581	612	606
Raw Materials	- -	140	182	172	209	215	225	218	208	227
Work In Process	- -	38	54	58	41	48	59	60	53	55
Finished Goods	- -	106	221	151	241	227	248	304	352	323
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	1,522	1,912	1,722	637	674	713	300	1,069	2,447	3,948
- Cash & Cash Equivalents	- -	74	213	151	341	248	26	92	111	282
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	10	392	115	42	7	-114	- -	- -	-1
+ Total Debt	- -	1,485	2,691	2,770	2,945	2,876	2,845	2,751	2,593	2,689
Enterprise Value	1,522	3,333	4,591	3,370	3,319	3,348	3,005	3,728	4,929	6,355
Total Capital	- -	1,495	3,065	2,510	2,703	2,610	2,328	2,264	1,989	2,157
Total Debt/Capital (%)	- -	99.32	87.81	110.36	108.96	110.21	122.24	121.51	130.38	124.69
Total Debt / EV	- -	0.45	0.59	0.82	0.89	0.86	0.95	0.74	0.53	0.42
EV/Sales	1.49	3.22	2.76	2.07	1.67	1.6	1.36	1.56	1.76	2.11
EV/EBITDA	4.96	12.29	11.05	49.31	9.58	7.84	7	7.96	8.43	10.23
EV/EBIT	5.56	14.8	16.51	- -	29.88	17.27	15.91	15.62	14.15	15.97
EV/Cash Flow to Firm	9.01	10.95	11.69	7.28	33.47	10.16	13.2	6.21	7.67	11.32
EV/Free Cash Flow to Firm	5.18	7.96	9.37	6.02	20.07	8.76	9.44	5.57	6.87	9.4
Diluted Market Cap	1,522	1,912	1,722	637	681	727	300	1,069	2,447	4,093
Diluted Enterprise Value	1,522	3,333	4,591	3,370	3,326	3,362	3,005	3,728	4,929	6,499
EV per Share	13.25	29.02	36.08	25.51	22.51	22.48	19.91	21.17	15.95	20.28
TTM Sales	1,018	1,034	1,663	1,626	1,993	2,094	2,212	2,394	2,794	3,019
TTM EBITDA	307	271	416	68	346	427	429	468	585	621
TTM Operating Income	274	225	278	-139	111	194	189	239	348	398
TTM Cash Flow to Firm	169	304	393	463	99	329	228	600	642	562
TTM Free Cash Flow to Firm	294	419	490	560	165	382	318	670	717	676

Multiples (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	6.35	5.49	4.96	6.42	1.53	2.47	1.93	2.58	6.61	9.01
EV/EBIT	5.56	14.8	16.51	- -	29.88	17.27	15.91	15.62	14.15	15.97
Enterprise Value	1,522	3,333	4,591	3,370	3,319	3,348	3,005	3,728	4,929	6,355
Low Price	12.28	7.75	12.8	2.27	2.4	3.89	1.95	1.24	5.01	6.68
EV/Sales	1.49	3.22	2.76	2.07	1.67	1.6	1.36	1.56	1.76	2.11
EV/EBITDA	4.96	12.29	11.05	49.31	9.58	7.84	7	7.96	8.43	10.23
Price/Earnings	7.34	11.41	- -	- -	7.4	67.14	- -	- -	- -	54.8
Price/Earnings Average	15.45	11.02	-14.4	-2.75	6.91	74.4	-3.79	-6.47	-18.69	39.57
Price/Earnings High	23.9	17.61	-18.35	-5.58	9.2	104.36	-5.93	-13.21	-25.05	56.58
Price/Earnings Low	6.8	5.31	-9.6	-0.83	3.89	54.53	-2.26	-2.6	-13.24	29.05
Price/Book Value	- -	- -	-96.01	-1.7	-2.37	-2.61	-0.75	-2.19	-4.05	-7.42
Price/Book Value Average	- -	- -	-136.32	-2.65	-2.22	-2.89	-1.22	-1.12	-3.62	-5.36
Price/Book Value High	- -	- -	-173.71	-5.38	-2.95	-4.06	-1.91	-2.28	-4.85	-7.67
Price/Book Value Low	- -	- -	-90.83	-0.8	-1.25	-2.12	-0.73	-0.45	-2.56	-3.94
Price/Tangible Book Value	- -	-4.28	-1.45	-0.44	-0.45	-0.51	-0.2	-0.73	-1.7	-3.21
Price/Tangible Book Value Average	- -	-4.14	-2.06	-0.68	-0.42	-0.57	-0.33	-0.37	-1.52	-2.32
Price/Tangible Book Value High	- -	-6.61	-2.63	-1.39	-0.56	-0.8	-0.51	-0.76	-2.03	-3.31
Price/Tangible Book Value Low	- -	-1.99	-1.37	-0.21	-0.24	-0.42	-0.19	-0.15	-1.08	-1.7
Price/Sales	1.49	1.85	1.04	0.39	0.34	0.34	0.14	0.45	0.88	1.31
Price/Sales Average	3.15	1.79	1.47	0.61	0.32	0.38	0.22	0.23	0.78	0.94
Price/Sales High	4.87	2.86	1.87	1.24	0.42	0.53	0.35	0.46	1.05	1.35
Price/Sales Low	1.38	0.86	0.98	0.18	0.18	0.28	0.13	0.09	0.55	0.69
Price/Cash Flow	13.23	8.17	6.88	373.46	1.78	2.95	4.61	3.09	8.29	11.61
Price/Cash Flow Average	27.84	7.89	9.77	583	1.66	3.27	7.57	1.57	7.4	8.39
Price/Cash Flow High	43.08	12.6	12.45	1,183.92	2.21	4.58	11.85	3.21	9.92	11.99
Price/Cash Flow Low	12.25	3.8	6.51	175.88	0.93	2.4	4.52	0.63	5.25	6.16
Price/Free Cash Flow Average	13.37	5.3	7.04	10.03	1.43	2.74	3.17	1.31	5.9	6.51
Price/Free Cash Flow High	20.68	8.47	8.97	20.36	1.9	3.84	4.95	2.68	7.91	9.3
Price/Free Cash Flow Low	5.88	2.55	4.69	3.02	0.8	2.01	1.89	0.53	4.18	4.78
EV/Sales Average	3.15	3.16	3.2	2.29	1.64	1.64	1.45	1.34	1.67	1.74
EV/Sales High	4.87	4.23	3.6	2.92	1.75	1.79	1.57	1.57	1.94	2.15
EV/Sales Low	1.38	2.24	2.71	1.87	1.51	1.54	1.36	1.2	1.44	1.49
EV/EBITDA Average	10.43	12.06	12.79	54.54	9.45	8.02	7.45	6.84	7.98	8.46
EV/EBITDA High	16.15	16.13	14.4	69.53	10.05	8.76	8.1	8.05	9.25	10.43
EV/EBITDA Low	4.59	8.52	10.83	44.38	8.66	7.52	6.99	6.15	6.89	7.24
EV/EBIT Average	11.69	14.52	19.11	-26.84	29.48	17.66	16.93	13.41	13.39	13.21
EV/EBIT High	18.09	19.42	21.52	-34.22	31.35	19.31	18.4	15.79	15.53	16.29
EV/EBIT Low	5.15	10.26	16.18	-21.84	27	16.58	15.87	12.05	11.57	11.31
Last Price	13.25	16.65	13.53	4.82	4.57	4.79	1.99	6.07	7.92	12.6
High Price	43.16	25.7	24.48	15.28	5.68	7.44	5.11	6.3	9.48	13.01
Enterprise Value Average	3,203	3,269	5,314	3,728	3,274	3,425	3,198	3,202	4,666	5,258
Enterprise Value High	4,957	4,373	5,985	4,752	3,483	3,744	3,476	3,769	5,410	6,483
Enterprise Value Low	1,410	2,311	4,498	3,033	2,999	3,214	2,999	2,878	4,030	4,500

Shares Outstanding	- -	115	127	147	148	149	151	307	310	315
Diluted Weighted Avg Shares	115	115	127	132	149	152	151	176	309	325
Basic Weighted Avg Shares	115	115	127	132	147	149	151	176	309	313
Revenue per Share	8.86	9	13.07	12.31	13.51	14.06	14.66	13.59	9.04	9.63
EBITDA per Share	2.67	2.36	3.27	0.52	2.35	2.87	2.84	2.66	1.89	1.98
Operating Income per Share	2.39	1.96	2.19	-1.05	0.75	1.3	1.25	1.36	1.13	1.27
Basic EPS, GAAP	1.81	1.46	-1.33	-2.74	0.62	0.07	-0.86	-0.48	-0.38	0.23
Basic EPS from Cont Ops	1.82	1.47	-1.58	-4.57	0.47	0.14	-1.69	-0.28	-0.24	0.41
Diluted EPS, GAAP	1.81	1.46	-1.33	-2.74	0.61	0.07	-0.86	-0.48	-0.38	0.22
Diluted EPS from Cont Ops	1.82	1.47	-1.58	-4.57	0.46	0.13	-1.69	-0.28	-0.24	0.39
Dividend per Share	1.75	3.27	1.44	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	1	2.04	1.97	0.01	2.57	1.62	0.43	1.96	0.96	1.08
Free Cash Flow per Basic Share	-0.08	1.04	1.2	-0.72	2.12	1.27	-0.17	1.57	0.71	0.72
Cash & Equivalents per Share	- -	0.65	1.68	1.14	2.32	1.66	0.17	0.52	0.36	0.9
Book Value per Share	- -	- -	-0.14	-2.84	-1.92	-1.83	-2.67	-2.77	-1.95	-1.7
Tangible Book Value per Share	- -	-3.89	-9.31	-11.02	-10.05	-9.35	-10.01	-8.34	-4.66	-3.93

Amneal Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)